| PERIOD ENDING | 31-Dec-08 |
| Total Revenue | 4,091 |
| Cost of Revenue | 2,266 |
|
| Gross Profit | 1,825 |
|
| Operating Expenses |
| Research Development |
-
|
| Selling General and Administrative | 1,698 |
| Non Recurring |
-
|
| Others | 189 |
| |
| Total Operating Expenses |
-
|
|
|
| Operating Income or Loss | (62) |
|
| Income from Continuing Operations |
| Total Other Income/Expenses Net | 0 |
| Earnings Before Interest And Taxes | (62) |
| Interest Expense | 115 |
| Income Before Tax | (178) |
| Income Tax Expense | 17 |
| Minority Interest |
-
|
| |
| Net Income From Continuing Ops | (195) |
|
| Non-recurring Events |
| Discontinued Operations |
-
|
| Extraordinary Items |
-
|
| Effect Of Accounting Changes |
-
|
| Other Items |
-
|
|
|
| Net Income | (195) |
| Preferred Stock And Other Adjustments |
-
|
|
| Net Income Applicable To Common Shares | ($195) |
0.09% Nasdaq 
1.04%
Income Statement
